SRRK Insider Trading
Insider Ownership Percentage: 19.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $67,569,198.50
Scholar Rock Insider Trading History Chart
This chart shows the insider buying and selling history at Scholar Rock by year and by quarter.
Skip ChartChart Data in Insider Trading History Table
Scholar Rock Share Price & Price History
Current Price: $34.60
Price Change: ▲ Price Increase of +0.05 (0.14%)
As of 03/14/2025 05:00 PM ET
Scholar Rock Insider Trading History
Scholar Rock Institutional Trading History
Data available starting January 2016
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery, development, and delivery of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of myostatin that is in Phase 3 clinical trial for the treatment of spinal muscular atrophy; and SRK-181, which has completed Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is developing a pipeline of product candidates to deliver novel therapies to treat a range of serious diseases, including neuromuscular disorders, cardiometabolic disorders, cancer, fibrosis, and iron-restricted anemia. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.
Read More on Scholar Rock
Today's Range
Now: $34.60
52 Week Range
Now: $34.60
Volume
1,093,825 shs
Average Volume
1,164,015 shs
Market Capitalization
$3.28 billion
P/E Ratio
N/A
Dividend Yield
N/A
Beta
0.59
Who are the company insiders with the largest holdings of Scholar Rock?
Scholar Rock's top insider shareholders include:
- Public Equities LP Invus (Major Shareholder)
- Samsara Biocapital Gp, Llc (Major Shareholder)
- Srinivas Akkaraju (Director)
- Jay T Backstrom (CEO)
- Edward H Myles (CFO)
- Junlin Ho (General Counsel)
- Caryn Parlavecchio (Insider)
- Mo Qatanani (Insider)
- Mo Qatanani (SVP)
- Jing L Marantz (Insider)
- Tracey Sacco (Insider)
Learn More about top insider investors at Scholar Rock.
Who are the major institutional investors of Scholar Rock?
Which institutional investors are selling Scholar Rock stock?
In the last quarter, SRRK stock was sold by these institutional investors:
- Samsara BioCapital LLC
- Redmile Group LLC
- abrdn plc
- Orbimed Advisors LLC
- Candriam S.C.A.
- Millennium Management LLC
- Clearbridge Investments LLC
- BIT Capital GmbH
Within the last year, company insiders that have sold Scholar Rock company stock include:
- Public Equities LP Invus (Major Shareholder)
- Samsara Biocapital Gp, Llc (Major Shareholder)
- Srinivas Akkaraju (Director)
- Jay T Backstrom (CEO)
- Edward H Myles (CFO)
- Junlin Ho (General Counsel)
- Caryn Parlavecchio (Insider)
- Mo Qatanani (Insider)
- Mo Qatanani (SVP)
Learn More investors selling Scholar Rock stock.
Which institutional investors are buying Scholar Rock stock?
Within the previous quarter, SRRK stock was acquired by institutional investors including:
- FMR LLC
- Marshall Wace LLP
- Norges Bank
- Fairmount Funds Management LLC
- Adage Capital Partners GP L.L.C.
- Wellington Management Group LLP
- Janus Henderson Group PLC
- Loomis Sayles & Co. L P
Within the previous year, these company insiders have bought Scholar Rock stock:
- Public Equities LP Invus (Major Shareholder)
- Samsara Biocapital Gp, Llc (Major Shareholder)
Learn More investors buying Scholar Rock stock.